SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is experiencing significant market interest and a trading halt following a string of major defense contracts and a high-profile partnership to develop AI-focused optical interconnect technology. The community is buzzing over the potential for a massive short squeeze and the strategic pivot toward high-growth AI infrastructure, with many investors holding long-term positions in anticipation of further institutional adoption.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is experiencing significant investor interest driven by its shift from research to the commercial deployment of its Dirac-3 platform and strategic photonic hardware acquisitions. The community is actively discussing the stock's potential for a short squeeze, fueled by high short interest and bullish institutional positioning, while debating whether current revenue levels can support its multi-billion dollar market valuation.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors digest a strong earnings beat and a significant guidance hike, with the community closely tracking the geopolitical impact of the Strait of Hormuz blockade on long-term supply constraints. Bullish sentiment remains high among retail holders who see the stock as an undervalued energy play, despite ongoing volatility driven by macro-economic uncertainty and conflicting reports regarding potential diplomatic resolutions in the region.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors digest a Financial Times report that activist investor Nelson Peltz's Trian Fund Management is seeking financing for a potential take-private bid for the company. Community discussion is heavily focused on the high short interest and the potential for a significant squeeze, with many retail investors debating a fair buyout price and expressing frustration over the company's lack of a permanent CEO and recent stock price volatility.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing intense volatility as investors weigh conflicting narratives of aggressive hyperscaler infrastructure demand against concerns over valuation and capacity bottlenecks. The community remains deeply divided, with bulls pointing to the company's critical role in the AI data center optical upgrade cycle while bears caution that the stock's parabolic ascent and historical lack of consistent profitability signal a potential correction.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of heated community debate as investors weigh the company's recent achievement of closing Phase 3 of the FAA's type certification process against persistent concerns regarding cash burn and the timeline for piloted transition flights. While supporters point to strong strategic partnerships and regulatory progress as proof of a viable commercial future, critics remain focused on production speed and transparency, creating a volatile environment where sentiment shifts rapidly ahead of upcoming earnings.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is trending due to significant momentum from positive preclinical data on its ovarian cancer treatment, which has ignited a battle between aggressive bulls targeting a breakout and skeptics focused on the company's dilution history. The community is closely watching the stock's low float and high short interest, with many traders anticipating a potential squeeze while others express caution regarding the long timeline for human clinical trials.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is seeing heightened volatility and intense social media discourse driven by the looming SpaceX IPO and recent concerns regarding the validity of indirect Anthropic holdings held through special purpose vehicles. Investors remain deeply divided, with some viewing the recent price action and dilution risks as a buying opportunity ahead of potential upside, while others warn of significant overvaluation relative to the fund's net asset value.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund is experiencing extreme volatility and intense community debate as investors grapple with the significant premium over its underlying net asset value. While bulls focus on the fund's direct exposure to high-growth AI and tech giants like Anthropic and SpaceX, bears and critics are actively highlighting potential concerns regarding lock-up expirations, structural sell-offs by insiders, and the risks inherent in its private-market valuation model.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense retail momentum as traders draw parallels between its specialized memory chips and the massive growth seen in major semiconductor stocks. The community is actively discussing a potential gamma squeeze driven by high call option interest and the company's perceived role as a critical infrastructure player for AI and defense.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.

AMPE
Ampio Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Historical Earnings

Latest AMPE News

AMPEAmpio Pharmaceuticals Inc